Page last updated: 2024-11-06

prednisolone and Cocarcinogenesis

prednisolone has been researched along with Cocarcinogenesis in 2 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Cocarcinogenesis: The combination of two or more different factors in the production of cancer.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Juasook, A1
Boonmars, T1
Wu, Z1
Loilome, W1
Veteewuthacharn, K1
Namwat, N1
Sudsarn, P1
Wonkchalee, O1
Sriraj, P1
Aukkanimart, R1
Matano, S1
Nakamura, S1
Kobayashi, K1
Misaki, T1
Matsuda, T1
Sugimoto, T1

Other Studies

2 other studies available for prednisolone and Cocarcinogenesis

ArticleYear
Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine.
    Pathology oncology research : POR, 2013, Volume: 19, Issue:1

    Topics: Animals; Bile Duct Neoplasms; Cell Transformation, Neoplastic; Cholangiocarcinoma; Chronic Disease;

2013
Decreased lymphocytic proliferation by mitogens in patients with transitional cell carcinoma of the renal pelvis subsequent to non-Hodgkin's lymphoma.
    American journal of hematology, 1996, Volume: 51, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Transitional C

1996